Five-year-old girls with high cholesterol are more likely to be overweight at age twelve

September 19, 2002

Most scientific literature has suggested that obesity precedes the development of blood lipid disorders such as abnormally high cholesterol. Even in very young children, overweight or obesity can set off a cascade of early risk factors for cardiovascular disease that includes hypercholesterolemia, hypertension, and insulin resistance. Tershakovec et al., publishing in the American Journal of Clinical Nutrition, found that normal-weight children may be hypercholesterolemic, and that this condition predisposes young girls to the development of overweight and obesity later in childhood.

The Bogalusa Heart study, which examined the early natural history of cardiovascular disease in children and young adults, enrolled 58 children with abnormally high cholesterol concentrations (hypercholesterolemia) and 215 children with normal cholesterol levels when they were 5 to 6 years old and followed them for the next 6 years. The group was equally divided between girls and boys, and 41% of the children were black. None of the children were obese at the start of the study. The only difference between the two groups other than cholesterol levels was that the non-hypercholesterolemic children were significantly taller than the hypercholesterolemic children. In the following years, the hypercholesterolemic girls' body mass indexes (BMI) increased at a greater rate than the non-hypercholesterolemic girls', and by age 11-12 years, 45.2% of the hypercholesterolemic girls were overweight or obese, in comparison to 21.6% of the non-hypercholesterolemic girls. This effect was independent of race. In the same age range for boys, BMIs were no different for hypercholesterolemic and non-hypercholesterolemic subjects.

Although the relationship between hypercholesterolemia and weight gain is unclear, the authors propose that abnormally high cholesterol may be a marker of an altered metabolism, which later results in excess adiposity. When the result is obesity, blood lipid disorders can become exacerbated, and blood pressure and insulin concentrations may increase.
-end-
Tershakovec, Andrew et al. Persistent hypercholesterolemia is associated with the development of obesity among girls: the Bogalusa Heart Study. Am J Clin Nutr 2002;76:730-5.

This media release is provided by The American Society for Clinical Nutrition to provide current information on nutrition-related research. This information should not be construed as medical advice. If you have a medical concern, consult your doctor. To see the complete text of this article, please go to:
http://www.faseb.org/ajcn/October2002/13044.Tershakovec.pdf

American Journal of Clinical Nutrition

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.